Patient-derived microvesicles/AIE luminogen hybrid system for personalized sonodynamic cancer therapy in patient-derived xenograft models
Source abstract
Abstract
Sonodynamic therapy (SDT), as an efficient way of tumor treatment, has the advantages of deep tumor penetration and high therapeutic efficacy. However, developing efficient sonosensitizers are still challenging. AIEgen-based SDT is rarely reported and it is urgent to develop novel AIEgen-active sonosensitizers. Furthermore, the AIEgen-based theranostic system is promisingly needed to be proved on PDX models to be closer to the clinic. Herein, we constructed a novel AIEgen based SDT system and found that DCPy has advantages over traditional sonosensitizers in SDT. Then, a patient-derived MVs/AIEgen hybrid system (AMVs) prepared by electroporation was used for personalized SDT in bladder cancer patient-derived xenograft (PDX) models. Impressively, AMVs displayed the superior tumor targeting ability and efficient personalized SDT therapy on PDX models, both of which were much more improved compared with PLGA/AIEgens nanoparticles and cell line-derived micro vesicles. This work provides new ideas for both the design of AIE-active sonosensitizers and the SDT treatment of cancers, further expanding the potential clinical application of AIEgens in the future.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Luminescence and Fluorescent Materials · Photoacoustic and Ultrasonic Imaging
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (59)
Show source-provided references
1. NIR-II-Excited intravital two-photon microscopy distinguishes deep cerebral and tumor vasculatures with an ultrabright NIR-I AIE luminogen
2. Constitutional isomerization enables bright NIR‐II AIEgen for brain‐inflammation imaging
3. A red-emissive antibody-AIEgen conjugate for turn-on and wash-free imaging of specific cancer cells10.1039/C7SC01054K ↗
4. Recent advances of optical imaging in the second near-infrared window
5. Near-infrared afterglow luminescent aggregation-induced emission dots with ultrahigh tumor-to-liver signal ratio for promoted image-guided cancer surgery10.1021/acs.nanolett.8b03936 ↗
6. In vivo photothermal inhibition of methicillin-resistant Staphylococcus aureus infection by in situ templated formulation of pathogen-targeting phototheranostics10.1039/D0NR00181C ↗
7. Mitochondrion-anchoring photosensitizer with aggregation-induced emission characteristics synergistically boosts the radiosensitivity of cancer cells to ionizing radiation10.1002/adma.201606167 ↗
8. Bright near-infrared aggregation-induced emission luminogens with strong two-photon absorption, excellent organelle specificity, and efficient photodynamic therapy potential10.1021/acsnano.8b03138 ↗
9. Hypoxia-tropic nanozymes as oxygen generators for tumor-favoring theranostics10.1016/j.biomaterials.2019.119635 ↗
10. Multifunctional AIEgens for future theranostics10.1002/smll.201601637 ↗
11. Tumor-Exocytosed exosome/aggregation-induced emission luminogen hybrid nanovesicles facilitate efficient tumor penetration and photodynamic therapy10.1002/anie.202003672 ↗
12. Photosensitizers with aggregation-induced emission: materials and biomedical applications10.1002/adma.201801350 ↗
13. AIE multinuclear Ir(III) complexes for biocompatible organic nanoparticles with highly enhanced photodynamic performance
14. Aggregation-induced emission: a trailblazing journey to the field of biomedicine10.1021/acsabm.8b00600 ↗
15. Massively evoking immunogenic cell death by focused mitochondrial oxidative stress using an AIE luminogen with a twisted molecular structure
16. Micro/nanoparticle-augmented sonodynamic therapy (SDT): breaking the depth shallow of photoactivation10.1002/adma.201602012 ↗
17. The photodegradation OF porphyrins IN cells can be used to estimate the lifetime OF singlet oxygen10.1111/j.1751-1097.1991.tb03669.x ↗
18. Nanoenzyme-augmented cancer sonodynamic therapy by catalytic tumor oxygenation10.1021/acsnano.8b00999 ↗
19. Metal-organic-framework-derived carbon nanostructure augmented sonodynamic cancer therapy
20. Multifunctional sonosensitizers in sonodynamic cancer therapy10.1039/C9CS00648F ↗
21. Sonodynamic therapy inhibits angiogenesis and tumor growth in a xenograft mouse model10.1016/j.canlet.2013.02.006 ↗
22. Evidence against singlet oxygen formation by sonolysis of aqueous oxygen-saturated solutions of Hematoporphyrin and Rose Bengal: the mechanism of sonodynamic therapy10.1016/S1350-4177(99)00042-5 ↗
23. Recent advances in sonodynamic approach to cancer therapy10.1016/S1350-4177(96)00024-7 ↗
24. Oxygen-self-produced nanoplatform for relieving hypoxia and breaking resistance to sonodynamic treatment of pancreatic cancer10.1021/acsnano.7b08225 ↗
25. Bioinorganic chemistry of titanium10.1021/cr1002886 ↗
26. Long-circulating Au-TiO2 nanocomposite as a sonosensitizer for ROS-mediated eradication of cancer10.1021/acs.nanolett.6b02547 ↗
27. Boosting the photodynamic therapy efficiency by using stimuli-responsive and AIE-featured nanoparticles10.1016/j.biomaterials.2019.119749 ↗
28. Hybrid nanospheres to overcome hypoxia and intrinsic oxidative resistance for enhanced photodynamic therapy10.1021/acsnano.9b09032 ↗
29. Self-assembly of AIEgens10.1016/j.ccr.2019.213142 ↗
30. Engineered nanomedicines with enhanced tumor penetration10.1016/j.nantod.2019.100800 ↗
31. Mucoadhesive cationic polypeptide nanogel with enhanced penetration for efficient intravesical chemotherapy of bladder cancer10.1002/advs.201800004 ↗
32. Synergistically enhanced mucoadhesive and penetrable polypeptide nanogel for efficient drug delivery to orthotopic bladder cancer10.34133/2020/8970135 ↗
33. Spatiotemporally targeted nanomedicine overcomes hypoxia-induced drug resistance of tumor cells after disrupting neovasculature10.1021/acs.nanolett.0c02515 ↗
34. Extracellular vesicles for tumor targeting delivery based on five features principle10.1016/j.jconrel.2020.03.039 ↗
35. Extracellular vesicle-based drug delivery systems for cancer treatment10.7150/thno.37097 ↗
36. Engineered cell‐derived microparticles Bi2Se3/DOX@MPs for imaging guided synergistic photothermal/low‐dose chemotherapy of cancer
37. Liposome-based engineering of cells to package hydrophobic compounds in membrane vesicles for tumor penetration10.1021/nl5047494 ↗
38. Delivery of chemotherapeutic drugs in tumour cell-derived microparticles10.1038/ncomms2282 ↗
39. Neutrophil membrane-derived nanovesicles alleviate inflammation to protect mouse brain injury from ischemic stroke
40. Progress, opportunity, and perspective on exosome isolation - efforts for efficient exosome-based theranostics10.7150/thno.41580 ↗
41. Active loading into extracellular vesicles significantly improves the cellular uptake and photodynamic effect of porphyrins10.1016/j.jconrel.2014.11.029 ↗
42. The softness of tumour-cell-derived microparticles regulates their drug-delivery efficiency10.1038/s41551-019-0405-4 ↗
43. Magnetic and folate functionalization enables rapid isolation and enhanced tumor-targeting of cell-derived microvesicles10.1021/acsnano.6b05630 ↗
44. Right Cu2- x S@MnS core-shell nanoparticles as a photo/H2O2-responsive platform for effective cancer theranostics10.1002/advs.201901461 ↗
45. Anti-RhoJ antibody functionalized Au@I nanoparticles as CT-guided tumor vessel-targeting radiosensitizers in patient-derived tumor xenograft model10.1016/j.biomaterials.2017.06.036 ↗
46. Tumor targeting via EPR: strategies to enhance patient responses10.1016/j.addr.2018.07.007 ↗
47. Rational design of cancer nanomedicine: nanoproperty integration and synchronization10.1002/adma.201606628 ↗
48. Pharmacological blockade of ASCT2-dependent glutamine transport leads to antitumor efficacy in preclinical models10.1038/nm.4464 ↗
49. Intravesical hydrogels as drug reservoirs10.1016/j.tibtech.2019.12.012 ↗
50. Identification and validation of stromal immunotype predict survival and benefit from adjuvant chemotherapy in patients with muscle-invasive bladder cancer10.1158/1078-0432.CCR-17-2687 ↗
51. Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy10.1038/ncomms13193 ↗
52. Multifunctional liposome: bright AIEgen-lipid conjugate with strong photosensitization10.1002/anie.201809641 ↗
53. Free radical intermediates in sonodynamic therapy
54. Unraveling cell type-specific targeted delivery of membrane-camouflaged nanoparticles with plasmonic imaging10.1021/acs.nanolett.0c01503 ↗
55. Tumor exosome-based nanoparticles are efficient drug carriers for chemotherapy10.1038/s41467-019-11718-4 ↗
56. FLIM reveals alternative EV-mediated cellular up-take pathways of paclitaxel10.1016/j.jconrel.2018.06.015 ↗
57. Tumor-exocytosed exosome/AIEgen hybrid nano-vesicles facilitate efficient tumor penetration and photodynamic therapy
58. Cancer cell membrane camouflaged nanoparticles to realize starvation therapy together with checkpoint blockades for enhancing cancer therapy10.1021/acsnano.8b03788 ↗
59. Intra/extracellular lactic acid exhaustion for synergistic metabolic therapy and immunotherapy of tumors10.1002/adma.201904639 ↗